von BartheldCSWangL.Prevalence of olfactory dysfunction with the omicron variant of SARS-CoV-2: a systematic review and meta-analysis. Cells. 2023;12:430. doi:10.3390/cells12030430
2.
SheltonJFShastriAJFletez-BrantK. 23andMe COVID-19 Team. AslibekyanSAutonA.The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste. Nature Genet. 2022;54:121-124. doi:10.1038/s41588-021-00986-w
3.
MoherDLiberatiATetzlaffJAltmanDG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi:10.1136/bmj.b2535
4.
World Health Organization. WHO coronavirus (COVID-19) dashboard. https://covid19.who.int. Accessed July 26, 2023.
LeeJJPetersonAMKallogjeriD, et al. Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: a randomized controlled trial for treatment of post-viral olfactory dysfunction. Am J Otolaryngol. 2022;43(2):103299. doi:10.1016/j.amjoto.2021.103299
7.
GuptaSLeeJJPerrinA, et al. Efficacy and safety of saline nasal irrigation plus theophylline for treatment of COVID-19-related olfactory dysfunction: the SCENT2 Phase 2 randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2022;148(9):830-837. doi:10.1001/jamaoto.2022.1573
TemmelAFQuintCSchickinger-FischerBKlimekLStollerEHummelT.Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg. 2002;128(6):635-641. doi:10.1001/archotol.128.6.635